Error: Could not add to watchlist. X

Credit Suisse Lux Global Biotech Innovators Equity Fund

+ Watchlist
CLBIEHE:LX
215.07
EUR
3.09
1.42%
As of 12:59 AM EST on 2/11/2016.
Fund Type
SICAV
52Wk Range
215.07 - 361.69
1 Yr Return
-28.10%
YTD Return
-29.76%
Previous Close
218.16
52Wk Range
215.07 - 361.69
1 Yr Return
-26.71%
YTD Return
-29.76%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 02/11/2016)
215.07
Total Assets (m USD) (on 02/11/2016)
156.257
Inception Date
02/27/2006
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
IRENE BEATRICE PUETTNER
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.92%
Expense Ratio
2.19%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 172.48 k 18.28 m 7.81
Amgen Inc 100.97 k 16.27 m 6.95
Celgene Corp 140.28 k 15.35 m 6.56
Biogen Inc 52.00 k 14.92 m 6.38
Regeneron Pharmaceuticals Inc 24.00 k 13.07 m 5.59
Vertex Pharmaceuticals Inc 85.00 k 11.00 m 4.70
Incyte Corp 95.00 k 10.85 m 4.64
Alexion Pharmaceuticals Inc 60.75 k 10.84 m 4.63
BioMarin Pharmaceutical Inc 95.44 k 9.10 m 3.89
Alkermes PLC 100.00 k 7.34 m 3.14
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
ADDRESS
Credit Suisse AG
PHONE
-